Phase 1 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women aged 18 or older who have been formally diagnosed with breast cancer that has come back or spread to other parts of the body
- People who have tumour tissue samples available that have been preserved in a standard way used by laboratories (confirm with trial site)
- People whose breast cancer has continued to grow or spread after already trying standard treatments
- People who have at least one tumour that can be measured on a scan
- People who are reasonably active and able to care for themselves, based on a standard medical scoring system (confirm with trial site for the specific score range)
- People who are expected to live for at least 12 weeks
- People whose blood, liver, and kidney function meet certain minimum levels set by the trial (confirm specific values with trial site)
- Women who could become pregnant must have had a negative pregnancy test within 7 days before joining, and must agree to use reliable contraception during the trial and for 8 weeks after the last dose
- People who are willing to follow the trial schedule, attend follow-up appointments, and cooperate with the study team
Who may not be able to join:
- People with active hepatitis B or active hepatitis C infection
- People with any serious ongoing illness, significant other health conditions, or an active infection
- People currently receiving any other cancer treatment
- People with a history of epilepsy or seizure-related conditions
- People who are pregnant or breastfeeding
- People who are unlikely to attend follow-up appointments or follow the trial requirements
- People who are known to be allergic to the study drugs
- People diagnosed with another type of cancer within the past 5 years, with some exceptions for certain treated skin cancers, cervical changes, or other cancers with no current evidence of disease (confirm specific exceptions with trial site)
- People whom the trial doctor determines should not participate for other reasons that could affect the study results
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yan-xia Shi, Doctor, Sun Yat-sen University
Phone: 86-020-87343486
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Dose-limiting toxicities (DLTs); Maximum Tolerated Dose (MTD)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.